Adenoviral expression of the cyclin-dependent kinase inhibitor p27Kip1: a strategy for breast cancer gene therapy.
Rakkar
A N
AN
Medical Breast Cancer Section, Medicine Branch, Division of Clinical Sciences, National Cancer Institute, Bethesda, MD 20892-1906, USA.
Li
Z
Z
Katayose
Y
Y
Kim
M
M
Cowan
K H
KH
Seth
P
P
D000256:Adenoviridae; D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics / Q000628:therapy*; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors*; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000378:metabolism*; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D015552:Injections, Intralesional; D008325:Mammary Neoplasms, Experimental / Q000235:genetics / Q000628:therapy*; D051379:Mice; D008819:Mice, Nude
D004791:Enzyme Inhibitors; D018844:Cyclin-Dependent Kinases